Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease

被引:58
|
作者
Tran Thi Mong Hiep [1 ]
Ismaili, Khalid [2 ]
Collart, Frederic [3 ]
Van Damme-Lombaerts, Rita [4 ]
Godefroid, Nathalie [5 ]
Ghuysen, Marie-Sophie [6 ,7 ]
Van Hoeck, Koen [8 ]
Raes, Ann [9 ]
Janssen, Francoise [2 ]
Robert, Annie [10 ]
机构
[1] Univ Pham Ngoc Thach, Dept Pediat, Nhi Dong Hosp Grall 2, Ho Chi Minh City, Vietnam
[2] Univ Libre Bruxelles, Dept Pediat Nephrol, Hop Univ Enfants Reine Fabiola, Brussels, Belgium
[3] Free Univ Brussels, Hop Univ Brugmann, Dept Nephrol, B-1020 Brussels, Belgium
[4] UZ Gasthuiberg, Dept Pediat Nephrol & Organ Transplantat, Leuven, Belgium
[5] Catholic Univ Louvain, Dept Nephrol, B-1200 Brussels, Belgium
[6] Ctr Hosp Chretien, Dept Pediat Nephrol, Liege, Belgium
[7] Ctr Hosp Univ Liege, Liege, Belgium
[8] Univ Ziekenhuis Antwerpen, Dept Pediat Nephrol, Edegem, Belgium
[9] Univ Ziekenhuis Gent, Dept Pediat Nephrol, Ghent, Belgium
[10] Catholic Univ Louvain, Dept Epidemiol & Biostat, B-1200 Brussels, Belgium
关键词
End stage renal failure; Mortality; Primary renal disease; Renal replacement therapy; CHRONIC-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; EPIDEMIOLOGY; GUIDELINES; INFANTS;
D O I
10.1007/s00467-009-1424-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this study was to report on the clinical characteristics and outcomes of Belgian children with chronic kidney disease (CKD). Between 2001 and 2005, we followed 143 new successive patients younger than 20 years of age with a glomerular filtration rate of < 60 ml/min/1.73 m(2) prospectively in a Belgian department of pediatric nephrology. The incidence of diagnosed CKD was 11.9 per million child population (pmcp), and the incidence of renal replacement therapy was 6.2 pmcp. There were 67% patients in CKD stage 3, 19% in CKD stage 4 and 14% in CKD stage 5. Patients with congenital anomalies of the kidney and urinary tract (CAKUTs), hereditary diseases and glomerular diseases were diagnosed at a median age of 1, 2 and 10 years, respectively. CAKUTs were the main causes of CKD, accounting for 59% of all cases. After 3, 4 and 5 years of follow-up, 27, 31 and 38% of patients treated conservatively, respectively, reached end-stage renal failure (ESRF). The progression rate to ESRF was eightfold higher in patients with CKD stage 4 than in those with CKD stage 3. Among our patient group, hereditary diseases progressed more rapidly to ESRF than CAKUTs. Transplantation was performed preemptively in 22% of these children. Infections and cardiovascular diseases were the main causes of death.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 50 条
  • [41] Relationship between liver function tests & cardiovascular risk factors in stage 3-5 pre-dialysis chronic kidney disease
    Selen, Tamer
    Akoglu, Hadim
    Agbaht, Kemal
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (3-4) : 397 - 402
  • [42] Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study
    Martinez-Castelao, Alberto
    Gorriz, Jose L.
    Portoles, Jose M.
    De Alvaro, Fernando
    Cases, Aleix
    Luno, Jose
    Navarro-Gonzalez, Juan F.
    Montes, Rafael
    De la Cruz-Troca, Juan J.
    Natarajan, Aparna
    Batlle, Daniel
    BMC NEPHROLOGY, 2011, 12
  • [43] Chronic Kidney Disease and Clinical Outcomes in Patients with Intracerebral Hemorrhage
    Beuscher, Vanessa D.
    Sprugel, Maximilian I.
    Gerner, Stefan T.
    Sembill, Jochen A.
    Madzar, Dominik
    Reindl, Caroline
    Lucking, Hannes
    Lang, Stefan
    Hoelter, Philip
    Kuramatsu, Joji B.
    Huttner, Hagen B.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (08)
  • [44] Impact of Chronic Kidney Disease in Chronic Total Occlusion Management and Clinical Outcomes
    Flores-Umanzor, Eduardo
    Cepas-Guillen, Pedro
    Alvarez-Contreras, Luis
    Caldentey, Guillem
    Castrillo-Golvano, Leticia
    Fernandez-Valledor, Andrea
    Salazar-Rodriguez, Anthony
    Arevalos, Victor
    Gabani, Rami
    Regueiro, Ander
    Brugaletta, Salvatore
    Roque, Merce
    Freixa, Xavier
    Martin-Yuste, Victoria
    Sabate, Manel
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 38 : 75 - 80
  • [45] Predictors of Vitamin D Deficiency in Predialysis Patients with Stage 3-5 Chronic Kidney Diseases in Southern China
    Feng, M.
    Lv, J.
    Huang, F. T.
    Liang, P. F.
    Fu, S.
    Zeng, Y. C.
    Tang, Y.
    Xu, A. P.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2017, 20 (10) : 1309 - 1315
  • [46] Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients
    Miyamoto, Masahito
    Kurita, Noriaki
    Suemitsu, Kotaro
    Murakami, Masaaki
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (04) : 356 - 364
  • [47] Clinical and Economic Outcomes in Medicare Beneficiaries with Stage 3 or Stage 4 Chronic Kidney Disease and Anemia: The Role of Intravenous Iron Therapy
    Knight, Tyler G.
    Ryan, Kellie
    Schaefer, Caroline P.
    D'Sylva, Lynell
    Durden, Emily D.
    JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (08): : 605 - 615
  • [48] Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non-dialysis-dependent stage 3-5 chronic kidney disease from the Salford Kidney Study
    Alexandre, Ana Filipa
    Stoelzel, Matthias
    Kiran, Amit
    Garcia-Hernandez, Alberto
    Morga, Antonia
    Kalra, Philip A. A.
    JOURNAL OF NEPHROLOGY, 2023, 36 (06) : 1639 - 1649
  • [49] Epidemiology of chronic kidney disease in children in Serbia
    Peco-Antic, Amira
    Bogdanovic, Radovan
    Paripovic, Dusan
    Paripovic, Aleksandra
    Kocev, Nikola
    Golubovic, Emilija
    Milosevic, Biljana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1978 - 1984
  • [50] Risk Profile in Chronic Kidney Disease Stage 3: Older versus Younger Patients
    McIntyre, Natasha J.
    Fluck, Richard J.
    McIntyre, Christopher W.
    Taal, Maarten W.
    NEPHRON CLINICAL PRACTICE, 2011, 119 (04): : C269 - C276